CS251799B2 - Method of bacampiciline hydrochloride stabilization - Google Patents

Method of bacampiciline hydrochloride stabilization Download PDF

Info

Publication number
CS251799B2
CS251799B2 CS858022A CS802285A CS251799B2 CS 251799 B2 CS251799 B2 CS 251799B2 CS 858022 A CS858022 A CS 858022A CS 802285 A CS802285 A CS 802285A CS 251799 B2 CS251799 B2 CS 251799B2
Authority
CS
Czechoslovakia
Prior art keywords
acid
hydrochloride
compounds
penicilová
ethyl acetate
Prior art date
Application number
CS858022A
Other languages
Czech (cs)
English (en)
Inventor
Ulf A Kjellberg
Per G H Nyqvist
Jan U Stenhede
Lars B Stenmark
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of CS251799B2 publication Critical patent/CS251799B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04—Preparation
    • C07D499/14—Preparation of salts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CS858022A 1984-11-09 1985-11-07 Method of bacampiciline hydrochloride stabilization CS251799B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8405611A SE8405611D0 (sv) 1984-11-09 1984-11-09 Process for stabilization of bacampicillin hydrochloride

Publications (1)

Publication Number Publication Date
CS251799B2 true CS251799B2 (en) 1987-08-13

Family

ID=20357678

Family Applications (1)

Application Number Title Priority Date Filing Date
CS858022A CS251799B2 (en) 1984-11-09 1985-11-07 Method of bacampiciline hydrochloride stabilization

Country Status (23)

Country Link
US (1) US4626532A (xx)
EP (1) EP0187626A1 (xx)
JP (1) JPS61115031A (xx)
KR (1) KR860004065A (xx)
CN (1) CN85108260A (xx)
AU (1) AU581694B2 (xx)
CS (1) CS251799B2 (xx)
DD (1) DD239206A5 (xx)
DK (1) DK509085A (xx)
EG (1) EG17292A (xx)
ES (1) ES8704176A1 (xx)
FI (1) FI854340A (xx)
GB (1) GB2167067B (xx)
GR (1) GR852706B (xx)
HU (1) HUT40135A (xx)
IL (1) IL76727A (xx)
NZ (1) NZ214096A (xx)
PH (1) PH21760A (xx)
PL (1) PL256116A1 (xx)
PT (1) PT81455B (xx)
SE (1) SE8405611D0 (xx)
YU (1) YU167085A (xx)
ZA (1) ZA858043B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2339147C (en) 1998-08-04 2009-04-21 Fujisawa Pharmaceutical Co., Ltd. Stabilized preparations of .beta.-lactam antibiotic
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
US8986781B2 (en) * 2005-10-27 2015-03-24 Corning Incorporated Immobilized multi-layer artificial membrane for permeability measurements (PAMPA)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293590A (en) * 1969-11-11 1972-10-18 Leo Pharm Prod Ltd New penicillanic acid derivatives
US3873521A (en) * 1970-09-17 1975-03-25 Astra Laekemedel Ab Esters of {60 -amino penicillins
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture

Also Published As

Publication number Publication date
GB2167067A (en) 1986-05-21
ZA858043B (en) 1987-04-29
IL76727A0 (en) 1986-02-28
KR860004065A (ko) 1986-06-16
PT81455B (en) 1987-09-17
AU581694B2 (en) 1989-03-02
IL76727A (en) 1989-09-10
DD239206A5 (de) 1986-09-17
FI854340A (fi) 1986-05-10
ES8704176A1 (es) 1987-03-16
EG17292A (en) 1990-08-30
HUT40135A (en) 1986-11-28
GB2167067B (en) 1988-06-22
EP0187626A1 (en) 1986-07-16
JPS61115031A (ja) 1986-06-02
YU167085A (en) 1988-12-31
US4626532A (en) 1986-12-02
FI854340A0 (fi) 1985-11-05
PL256116A1 (en) 1988-05-12
PT81455A (en) 1985-12-01
CN85108260A (zh) 1986-04-10
DK509085A (da) 1986-05-10
SE8405611D0 (sv) 1984-11-09
PH21760A (en) 1988-02-18
DK509085D0 (da) 1985-11-05
NZ214096A (en) 1988-09-29
GB8527612D0 (en) 1985-12-11
GR852706B (xx) 1986-03-10
AU4938285A (en) 1986-05-15
ES548698A0 (es) 1987-03-16

Similar Documents

Publication Publication Date Title
KR0183027B1 (ko) 류코트리엔의 작용에 대한 길항작용이 요구되는 질환의 치료용 약학 조성물 및 이의 제조 방법
US4404183A (en) Sustained release pharmaceutical composition of solid medical material
JP4608031B2 (ja) アミノ酸／シクロデキストリン混合物による酸感受性ベンズイミダゾール類の安定化
US4138475A (en) Sustained release pharmaceutical composition
CA1147650A (en) Sustained release pharmaceutical compositions
CA2008972C (en) Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
CZ316594A3 (en) Stomach protecting stable omeprazole preparations having the form of micro-capsules and process for preparing thereof
KR20120089461A (ko) 향상된 안정성을 갖는 (ｚ)-2-시아노-3-하이드록시-부트-2-엔산-(4''-트리플루오로메틸페닐)-아미드 정제 제형
FR2550092A1 (fr) Preparation medicamenteuse solide a deux phases et son procede d'obtention
US5424301A (en) Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents
US4897267A (en) Microparticles comprising a biodegradable polymer controlling the release of an antimalaria active principle, pharmaceutical compositions comprising it and process for its preparation
CS251799B2 (en) Method of bacampiciline hydrochloride stabilization
US4533552A (en) Stabilization of azulene derivatives
JP3456211B2 (ja) 持続性製剤
CA2002337C (en) Controlled release flecainide acetate formulation
KR950015059B1 (ko) 오메프라졸의 신규 경구용 약제
DE69728043T2 (de) Thermisch immobilisierte polysaccharidderivate
WO2002005745A2 (en) The process of manufacturing pharmaceutical grade tannates
JPH0215522B2 (xx)
AU2004233606A1 (en) Pellet formulations of acid-labile antiulcer benzimidazole compounds
JPS61212539A (ja) α−クロロプロピオン酸類の光学分割方法
KR0147461B1 (ko) 경구용 오메프라졸 제제
WO2005023225A1 (en) Cilostazol adsorbate
EP0667153A1 (en) Method of manufacturing composition for solid medicine
JPH04244098A (ja) 高純度の結晶状ペプチドａｒｇ−ｌｙｓ−ａｓｐ及びａｒｇ−ｌｙｓ−ａｓｐ−ｖａｌ並びにその製造方法